Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). (Q34308370)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). |
scientific article |
Statements
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301) (English)
Jean-Marc Phelip
Laetitia Dahan
Frank Bonnetain
Emmanuel Mitry
Mohamed Gasmi
Jean-Luc Raoul
Stéphane Cattan
Pierre Michel
Jean-Louis Legoux
Philippe Rougier
Laurent Bedenne
Jean-François Seitz
Fédération Francophone de Cancérologie Digestive
Bruno Chauffert
1 November 2010
1 reference
1 reference
1 reference
1 reference